التفاصيل البيبلوغرافية
| العنوان: |
Leasing health technologies- an affordable and effective reimbursement strategy for innovative technologies? |
| المؤلفون: |
Christopher McCabe, Richard Edlin, Peter Hall, Klemens Wallner |
| المصدر: |
Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Working Papers. |
| الوصف: |
The challenge of implementing high cost innovative technologies in health care systems operating under significant budgetary pressure has seen a radical shift in the health technology reimbursement landscape. New reimbursement strategies attempt to reduce the risk of making the wrong decision; i.e. paying for a technology that is not good value for the health care system, whilst promoting the adoption of innovative technologies into clinical practice. However, the remaining risk is not shared between the manufacturer and the health care payer at the individual purchase level; it continues to be passed from the manufacturer to the payer at the time of purchase. In this paper we propose a health technology payment strategy – Technology Leasing Reimbursement Scheme (TLRS) - which allows the sharing of risk between the manufacturer and the payer; the replacing of upfront payments with a stream of payments spread over the expected duration benefit from the technology, subject to the technology delivering the claimed health benefit. Using trastuzumab (Herceptin) in Early Breast Cancer as an exemplar technology we show how a TLRS not only reduces the total budgetary impact of the innovative technology, it also truly shares risk between the manufacturer and the health care system, whilst reducing the value of further research and thus promoting the rapid adoption of innovative technologies into clinical practice. |
| Original Identifier: |
1302 |
| نوع الوثيقة: |
redif-paper |
| اللغة: |
English |
| الإتاحة: |
https://ideas.repec.org/p/lee/wpaper/1302.html |
| رقم الأكسشن: |
edsrep.p.lee.wpaper.1302 |
| قاعدة البيانات: |
RePEc |
